Further study indicates that vascular endothelial growth factor A (VEGFA) is a novel target of miR-101, and CAFs-derived VEGFA mediates the effect of miR-101 on migration and invasion of lung cancer cells [61], suggesting a new combination of VEGF and miR-101 for metastasis therapy. Here, VEGFA is linked to lung carcinoma.